News Headlines

Display #
Phase III data in The Lancet show Novartis siponimod significantly improved outcomes in patients with secondary progressive MS
GSW Names New Executive Creative Director
LevLane Named AOR For Ilera Healthcare
Galafold Approved for Fabry Disease in Japan
Career Conversation 18 – Sharpening Your Political Know-How
Indivior loses another case in battle to protect opioid addiction drug
China Reform, Capital To Spur Partnering With U.S. Healthcare Companies
Two-drug HIV regimen wins EU panel approval
Two Really Big Fish That Got Away
Pfizer’s Chantix fails study in adolescent smokers
How 23andMe Quelled FDA Concerns About DTC Breast Cancer Gene Test
EMA panel recommends against clot prevention drug
How To Build A Marijuana Unicorn: An Interview With MedMen Spokesman Daniel Yi
GSK Walks Away From Acquiring Pfizer Consumer Goods Unit
Adaptive Designs in Clinical Trials Conference 2018
Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies
Medical expansion has improved health - with one exception
Britain’s use of copycat biotech drugs takes off
How To Ride A Marijuana Unicorn: An Interview With MedMen Spokesman Daniel Yi
Scientists develop brain scanner in a helmet
Intel And Healthcare Partners Lean Into AI At SOLVE Event
Longtime U.S. AIDS researcher picked to run CDC
The Value Wave: How Pharma Marketers Can Catch It
Mumps Vaccine Effectiveness Declines Over Time. But There's A Solution
Major Risk To Cannabis Stocks On Verge Of Lifting
Brace For 10% Obamacare Rate Hikes After Congress Snubs ACA Stabilization
Cimzia label update marks major advance for women of childbearing age with chronic inflammatory disease in the U.S.
AbbVie not seeking faster approval for cancer drug
HealthSpark 2018
What You Need To Know About The Yellow Fever Epidemic In Brazil